Re: All-Cause Mortality in Randomized Trials of Cancer Screening
نویسندگان
چکیده
منابع مشابه
Re: All-cause mortality in randomized trials of cancer screening.
To support their argument that results of cancer screening trials based on disease-specific mortality are unreliable, Black et al. (1) compared the treatment effect measured by disease-specific mortality with the effect measured by all-cause mortality in 12 such trials. They found “major inconsistencies” between the two measures. We disagree with their interpretation and illustrate our reasons ...
متن کاملAll-cause mortality in randomized trials of cancer screening.
BACKGROUND The most widely accepted end point in randomized cancer screening trials is disease-specific mortality. The validity of this end point, however, rests on the assumption that cause of death can be determined accurately. An alternative end point is all-cause mortality, which depends only on the accurate ascertainment of deaths and when they occur. We compared disease-specific and all-c...
متن کاملHemoglobin Screening Independently Predicts All-Cause Mortality.
Objective .- Determine if the addition of hemoglobin testing improves risk prediction for life insurance applicants. Method .- Hemoglobin results for insurance applicants tested from 1993 to 2007, with vital status determined by Social Security Death Master File follow-up in 2011, were analyzed by age and sex with and without accounting for the contribution of other test results. Results .- Hem...
متن کاملIntentional Weight Loss and All-Cause Mortality: A Meta-Analysis of Randomized Clinical Trials
BACKGROUND Obesity is associated with increased mortality, and weight loss trials show rapid improvement in many mortality risk factors. Yet, observational studies typically associate weight loss with higher mortality risk. The purpose of this meta-analysis of randomized controlled trials (RCTs) of weight loss was to clarify the effects of intentional weight loss on mortality. METHODS 2,484 a...
متن کاملMeasuring mortality reductions in cancer screening trials.
Randomized trials involving large numbers of people and long follow-up have helped measure the mortality reductions achievable by screening for cancer. However, in many of these trials, the reported reductions have been modest. Part of the reason is the inappropriate way the reductions have been calculated. Analyses have largely ignored the fact that there is a time window in the first several ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JNCI Journal of the National Cancer Institute
سال: 2002
ISSN: 0027-8874,1460-2105
DOI: 10.1093/jnci/94.11.863